scholarly journals Safety, tolerability and pharmacokinetics and pharmacodynamics of HL2351, a novel hybrid fc‐fused interleukin‐1 receptor antagonist, in healthy subjects: A first‐in‐human study

2020 ◽  
Vol 86 (2) ◽  
pp. 372-379
Author(s):  
Jaeseong Oh ◽  
Ki Young Huh ◽  
Young‐Gyu Cho ◽  
Ji‐Eun Cha ◽  
Se‐Jin Kim ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Healthy Subjects ◽  
Interleukin 1 ◽  
Human Study ◽  
Pharmacokinetics And Pharmacodynamics ◽  
Interleukin 1 Receptor Antagonist

Mesenchymal Stem Cell-Derived Interleukin 1 Receptor Antagonist Promotes Macrophage Polarization and Inhibits B Cell Differentiation

Stem Cells ◽  
2015 ◽  
Vol 34 (2) ◽  
pp. 483-492 ◽  
Author(s):  
Patricia Luz-Crawford ◽  
Farida Djouad ◽  
Karine Toupet ◽  
Claire Bony ◽  
Marcella Franquesa ◽  
...  
Keyword(s):  
Stem Cell ◽  
Cell Differentiation ◽  
Mesenchymal Stem Cell ◽  
B Cell ◽  
Receptor Antagonist ◽  
Macrophage Polarization ◽  
Interleukin 1 ◽  
B Cell Differentiation ◽  
Interleukin 1 Receptor Antagonist
Sign in / Sign up

Export Citation Format

Share Document